Irloxacin and E-3846 are two new fluorinated quinolones. We evaluated the activities of these antimicrobial agents, ciprofloxacin, ofloxacin, enoxacin, pefloxacin, norfloxacin, and nalidixic acid against 1,161 bacterial strains. Ciprofloxacin was the most active quinolone. Irloxacin did not show great activity. The activity of E-3846 against gram-negative bacteria was similar to those of ofloxacin and pefloxacin, and E-3846 was the most active quinolone against gram-positive bacteria and anaerobes.
per spot, and results were noted after overnight incubation at 37°C in an aerobic atmosphere, except for Haemophilus, Neisseria, Legionella, and Branhamella spp., which were incubated in 5% C02, and anaerobes, which were incubated in an atmosphere of 10% C02-90% nitrogen. Campylobacter * Corresponding author.
(Helicobacter) pylori susceptibility studies were performed as previously described (3) . Plates were inoculated with a Steers replicator. Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 13883, Pseudomonas aeruginosa ATCC 27853, Bacteroides fragilis ATCC 25285, and Bacteroides thetaiotaomicron ATCC 29741 were used for quality control.
The susceptibilities of the 1,161 clinical isolates to the quinolones tested are presented in Table 1 . The most active quinolone against all species and genera of enterobacteria and Pseudomonas was ciprofloxacin. Against Acinetobacter calcoaceticus, ofloxacin and pefloxacin were slightly more active than ciprofloxacin. E-3846 showed activity similar to or slightly lower than those of ofloxacin, pefloxacin, and norfloxacin. Irloxacin was more active than nalidixic acid only. Against Haemophilus influenzae, Neisseria gonorrhoeae, and Moraxella (Branhamella) catarrhalis, both Ilactamase producers and non-1-lactamase producers, all fluorinated quinolones were highly active. E-3846 showed activity similar to those of the most active quinolones, while irloxacin was among the less active agents. As a group, the fluorinated quinolones showed moderate activity against Brucella spp. and L. pneumophila, ciprofloxacin and E-3846 also being the most active. E-3846 and ciprofloxacin were the most active quinolones against C. pylori. However, the in vitro activity of quinolones against this organism does not always correlate with in vivo activity. Against gram-positive bacteria, E-3846 was most active while enoxacin, norfloxacin, and irloxacin were the least active fluorinated quinolones. E-3846 also showed the best overall activity against Bacteroides spp. Irloxacin had activity similar to those of ciprofloxacin and ofloxacin.
Irloxacin is structurally similar to norfloxacin and pefloxacin. The C-7 substituent of irloxacin is a pyrrolyl, in contrast to the piperazin-1-yl found in norfloxacin and the 4-methyl-piperazin-1-yl found in pefloxacin. Nevertheless, the inclusion of this five-membered heterocyclic ring instead of the six-membered rings of norfloxacin and pefloxacin did not improve activity overall, since irloxacin was less active against gram-negative bacteria and only slightly more active against gram-positive bacteria and anaerobes.
E-3846 is structurally related to ciprofloxacin in the same way that irloxacin is related to norfloxacin, i.e., the only difference between E-3846 and ciprofloxacin is the pyrrolyl C-7 substituent instead of the piperazin-1-yl C-7 substituent of ciprofloxacin. In contrast to irloxacin, E-3846 showed good activity against gram-negative bacteria, likely due to the optimal steric, spatial, and electronic interactions of the 
